Sources: La Tercera
Argentina begins administering booster doses of the COVID-19 vaccine for people over the age of 50 years old and people with immunization problems. 2021-11-2
Argentina surpasses 60 million doses of the COVID-19 vaccine administered, with 28.6 million Argentines having received one dose and 17.7 million being fully vaccinated. 2021-09-11
Health minister Carla Vizzotti reports that Argentina has applied nearly 32 million doses of the COVID-19 vaccine. Argentina has so far reported 4.9 million cases and over 105,000 deaths from COVID-19. 2021-07-31
The Ministry of Health approves the emergency use of the Sinopharm BBIBP-CorV vaccine, making it the third vaccine to be authorized for use in the country. 2021-06-4
President Rodrigo Duterte receives his first dose of the Sinopharm BBIBP-CorV vaccine. 2021-05-3
The Drug Regulatory Authority of Pakistan grants emergency use authorisation of the Sinopharm BBIBP-CorV vaccine for people over 60 years of age. 2021-03-5
The United Arab Emirates announces that they will roll out the Sinopharm COVID-19 vaccine to all adult UAE citizens. 2020-12-22
Bahrain grants emergency use approval for a vaccine candidate produced in a partnership between Sinopharm and Abu Dhabi-based artificial intelligence and cloud computing company Group 42 on frontline workers. 2020-11-3
Sinopharm began Phase III trials in Peru starting with two dozen people, with the goal to vaccinate 6,000 people between the ages of 18 and 75. So far, Sinopharm has given 30,000 doses to volunteers and another 10,000 participants have received double doses in Bahrain and the United Arab Emirates, with additional trials planned for Morocco and Argentina. 2020-09-10